16 . January , 2019 - Wednesday
Check todays hot topics or new products

Find a Drug: Advanced

Please Sign in or Register

All about: Memantine Hydrochloride

Big Image Pronouncation: (meh-MAN-teen HIGH-droe-KLOR-ide)
Class: NMDA receptor antagonist

Trade Names:
Namenda
- Tablets 5 mg
- Tablets 10 mg
- Oral solution 2 mg/mL

Mechanism of Action

Pharmacology

It is postulated that memantine exerts its therapeutic effect as a low to moderate affinity, uncompetitive nervous system N-methyl-D-aspartate (NMDA) receptor antagonist by binding preferentially to the NMDA receptor-operated cation channels.

Pharmacokinetics

Absorption

Well absorbed from the GI tract, reaching C max in about 3 to 7 h.

Distribution

Vd is 9 to 11 L/kg. Plasma protein binding is 45%.

Metabolism

Little metabolism with 57% to 82% excreted unchanged in the urine and remainder eliminated as 3 polar metabolites that possess minimal activity.

Elimination

Terminal elimination t ½ is about 60 to 80 h. Renal elimination involves active tubular secretion moderated by pH dependent tubular reabsorption.

Special Populations

Elderly

Pharmacokinetics similar in young and elderly.

Gender

Women had approximately 45% greater exposure than men; however, there was no difference in exposure when body weight was taken into account.

Indications and Usage

Treatment of moderate to severe dementia of the Alzheimer type.

Unlabeled Uses

Treatment of vascular dementia.

Contraindications

Standard considerations.

Dosage and Administration

Adults

PO Start with 5 mg daily. Increase the dose in 5 mg increments to 5 mg twice daily, 15 mg/day (5 and 10 mg as separate doses), and 10 mg twice daily. The minimum recommended interval between dose increases is 1 wk.

General Advice

  • May be taken alone or in combination with other medications for Alzheimer dementia.
  • Administer without regard to meals. Administer with food if GI upset occurs.
  • Oral solution is sugar-free and peppermint flavored.
  • To prepare oral solution dosing device, remove dosing syringe with green cap and plastic tube from protective plastic bag. Remove child-resistant cap and seal from bottle. Insert plastic tube fully into bottle and screw green cap tightly onto bottle by turning cap clockwise (to right).
  • To prepare dose of oral solution, while keeping bottle upright on table remove lid to uncover opening on top of cap, insert tip of syringe (plunger fully depressed), hold syringe and gently pull the plunger of syringe to draw memantine solution into syringe. Remove syringe from opening of cap, invert syringe and slowly press plunger to level that push out any large air bubbles that may be present (tiny bubbles will not affect dose).
  • Administer oral solution directly from syringe into mouth.

Storage/Stability

Store tablets and oral solution at controlled room temperature (59° to 86°F).

Drug Interactions

Drugs eliminated via renal mechanisms (eg, cimetidine, hydrochlorothiazide, nicotine, quinidine, ranitidine, triamterene)

Plasma concentrations of both drugs may be altered.

Other NMDA antagonists (eg, amantadine, dextromethorphan, ketamine)

Has not been studied; use with caution.

Urinary alkalinizers (eg, carbonic anhydrase inhibitors, sodium bicarbonate)

Renal Cl of memantine is reduced about 80% under alkaline urine conditions at pH 8.

Laboratory Test Interactions

None well documented.

Adverse Reactions

Cardiovascular

Hypertension (4%); cardiac failure, syncope (at least 1%).

CNS

Dizziness (7%); confusion, headache (6%); hallucination, somnolence (3%); aggressive reaction, ataxia, cerebrovascular accident, hypokinesia, transient ischemic attack, vertigo (at least 1%).

Dermatologic

Rash (at least 1%).

EENT

Cataract, conjunctivitis (at least 1%).

GI

Constipation (5%); vomiting (3%).

Genitourinary

Frequent micturition (at least 1%).

Hematologic

Anemia (at least 1%).

Metabolic-Nutritional

Decreased weight, increased alkaline phosphatase (at least 1%).

Musculoskeletal

Back pain (3%).

Respiratory

Coughing (4%); dyspnea (2%); pneumonia (at least 1%).

Miscellaneous

Pain (3%); fatigue (2%);.

Precautions

Pregnancy

Category B .

Lactation

Undetermined.

Children

Safety and efficacy not established.

Renal Function

It is likely that memantine exposure will be increased in patients with moderate renal function impairment. Consider dose reduction. Administration of memantine is not recommended in severe renal function impairment.

GU conditions

Conditions that raise urine pH may decrease urinary elimination of memantine, resulting in increased plasma levels.

Seizures

Has not been studied in patients with seizure disorders.

Overdosage

Symptoms

Loss of consciousness, psychosis, restlessness, somnolence, stupor, visual hallucinations.

Patient Information

  • Advise patient or caregiver that this drug does not alter the Alzheimer process and that the efficacy of the medication may decrease over time.
  • Instruct patient or caregiver to continue using other medications for dementia as prescribed by health care provider.
  • Advise patient or caregiver to review the patient information leaflet carefully before starting therapy and to read and check for new information each time the medication is refilled.
  • Advise patient or caregiver that medication is started at a low dose and gradually increased to the max dose at intervals of at least 1 wk. Review dose escalation schedule with patient or caregiver.
  • Advise patient or caregiver that doses greater than 5 mg are taken twice daily, without regard to meals, but to take with food if GI upset occurs.
  • Ensure patient or caregiver using oral solution understands how to attach the green cap and plastic tube to new bottles of oral solution, withdraw prescribed dose using dosing syringe, and administer the dose.
  • Advise patient or caregiver not to discontinue the drug or change the dose unless advised by health care provider.
  • Caution patient or caregiver not to increase the dose of memantine if Alzheimer symptoms do not appear to be improving or appear to be getting worse, but to notify health care provider.
  • Caution patient that memantine may cause drowsiness or dizziness and to use caution while driving or performing other activities requiring mental alertness or coordination until tolerance is determined.

Recent Drug Updates at DrugIndexOnline:





Depacon Depacon
Some commonly used brand names are: In the U.S.— Depacon 2 Depakene 3 Depakote 1 Depakote Sprinkle 1 In Canada— Alti-Valproic 3 Depakene 3 Deproic 3 Dom-Valproic 3 Epival 1 Med Valproic 3 Novo-Valproic 3 Nu-Valproic 3 Penta-Valproic 3 pms-Valproic Acid 3 pms-Valproic Acid E.C. 3 more...

DextroStat DextroStat
Generic Name: dextroamphetamine sulfate Dosage Form: Tablets, usp cii Warning AMPHETAMINES HAVE A HIGH POTENTIAL FOR ABUSE. ADMINISTRATION OF AMPHETAMINES FOR PROLONGED PERIODS OF TIME MAY LEAD TO DRUG DEPENDENCE AND MUST BE AVOIDED. PARTICULAR ATTENTION SHOULD BE PAID TO THE POSSIBILITY OF SU more...

Imodium A-D Solution Imodium A-D Solution
Generic Name: Loperamide Oral Solution (loe-PER-a-mide) Brand Name: Imodium A-DImodium A-D Solution is used for:Treating symptoms of diarrhea (including traveler's diarrhea). Imodium A-D Solution is an antidiarrheal agent. It works by slowing the movement of bowel contents. Do NOT use Imodium A- more...

Ircon Ircon
Generic Name: ferrous fumarate (FEHR russ FEW ma rate) Brand Names: Femiron, Feostat, Ferret, Fumasorb, Hemocyte, Ircon, Nephro-Fer What is Ircon (ferrous fumarate)? Ferrous fumarate is a form of the mineral iron. Iron is important for many functions in the body, especially for the tran more...

Levulan Kerastick Levulan Kerastick
Generic Name: aminolevulinic acid hydrochloride Dosage Form: Topical solution DESCRIPTION LEVULAN® KERASTICK® (aminolevulinic acid HCl) for Topical Solution, 20%, contains the hydrochloride salt of aminolevulinic acid (ALA), an endogenous 5-carbon aminoketone. Aminolevulinic acid HCl (AL more...

Minocycline Dental Minocycline Dental
Some commonly used brand names are: In the U.S.— Arestin Category Antibacterial, dental Description Minocycline (mi-noe-SYE-kleen) is used to help treat periodontal disease (a disease of your gums). Periodontal disease is caused by bacteria growing beneath the gum line. Minocycli more...

Mycelex Troches Mycelex Troches
Generic Name: Clotrimazole Troches (kloe-TRIM-uh-zole) Brand Name: MycelexMycelex Troches is used for:Treating or preventing fungal infections of the mouth and throat. Mycelex Troches is an antifungal agent. It kills sensitive fungi by binding to the fungal cell membrane and weakening it. This a more...

Phenelzine Phenelzine
Some commonly used brand names are: In the U.S.— Nardil 2 Parnate 3 Marplan 1 In Canada— Nardil 2 Parnate 3 Note: For quick reference, the following antidepressants are numbered to match the corresponding brand names. This information applies to the following medicines: more...